These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1361666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms underlying the effects of amphetamine on particulate PKC activity.
    Giambalvo CT.
    Synapse; 2004 Feb; 51(2):128-39. PubMed ID: 14618680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT, Wagner RL.
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [Abstract] [Full Text] [Related]

  • 8. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ.
    Tarazi FI, Kula NS, Zhang K, Baldessarini RJ.
    Neuropharmacology; 2000 Aug 23; 39(11):2133-8. PubMed ID: 10963756
    [Abstract] [Full Text] [Related]

  • 9. Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism.
    Park YH, Kantor L, Guptaroy B, Zhang M, Wang KK, Gnegy ME.
    J Neurochem; 2003 Dec 23; 87(6):1546-57. PubMed ID: 14713310
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase C and dopamine release--III. Effect of dopamine depleting drugs.
    Giambalvo CT.
    Biochem Pharmacol; 1989 Dec 15; 38(24):4445-54. PubMed ID: 2574975
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA, Crawford CA, Nonneman AJ.
    Psychopharmacology (Berl); 1992 Dec 15; 106(4):502-10. PubMed ID: 1349753
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M, McDougall SA.
    Pharmacol Biochem Behav; 1993 Aug 15; 45(4):797-802. PubMed ID: 8105488
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA, McDougall SA, Bardo MT.
    Neuropharmacology; 1994 Dec 15; 33(12):1559-65. PubMed ID: 7760979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA.
    J Neurochem; 2003 May 15; 85(4):898-910. PubMed ID: 12716422
    [Abstract] [Full Text] [Related]

  • 19. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan 15; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 20. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q, Bubula N, Brown J, Wang Y, Kondev V, Vezina P.
    Neurosci Lett; 2016 May 27; 622():78-82. PubMed ID: 27113203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.